Categories

About IVD

Diagnostic priorities for 2025

Diagnostic priorities for 2025

The year 2025 confirmed the growing trend of personalized medicine, in which molecular biological diagnostics is no longer an add-on but is becoming a standard tool for clinical decision-making. Take a look at which specific items from our portfolio might be useful for you.

 

Thrombosis Prevention and Metabolic Pathways – HEMO line

The diagnosis of inherited thrombophilia has become standard practice in laboratories. Among our most popular kits are:

You may also find useful the kits for analysis of homocysteine metabolism and the folate cycle, which complement these two pillars:

 

Toxicity Prediction and Therapy Optimization – PHARM line

In the field of pharmacogenetics, kits designed for screening genotypes associated with the risk of severe adverse effects are of particular interest. These tests are key to individualizing the dosing of cytostatics and immunosuppressants in oncology, hematology, and gastroenterology:

We should also not forget two additional kits that are essential for therapy individualization:

 

From Intolerance to Immunity – GENETIC line

In this category, kits are often sold in high volumes, mainly due to their use in the differential diagnosis of common diseases:

Our portfolio, however, includes many additional products, such as kits for the diagnosis of hemochromatosis gb GENETIC HFE. Last but not least, we also offer gb GENETIC Gilbert and gb GENETIC APOE.

 

Oncological Monitoring and Microbial Diagnostics – ONCO line

In oncology, kits for monitoring myeloproliferative disorders and treatment response are also among the most popular:

 

Technical Characteristics of Bestselling Assays

The success of these products on the market in 2025 is based on their technical design. All kits are based on real-time PCR using TaqMan probes, with a unified temperature profile and all-in-one reagents, enabling laboratories to benefit from:

  • Simple and user-friendly operation for high sample throughput

  • Easy and rapid data interpretation

  • Compatibility with a wide range of commonly used real-time PCR cyclers

Do you have all these assays sufficiently stocked in your inventory?

If you are planning to replenish your stock or have any questions regarding these or other products, please do not hesitate to contact our sales department.

 

Leona Hofmeisterová

Zuzana Preclíková

 

Recommended products
Recommended products
New
gb PHARM BCHE gb PHARM BCHE

gb PHARM BCHE gb PHARM BCHE

The CE IVD kit is used for determination of genotype of five polymorphisms: A (D70G, rs1799807), K (A539T, rs1803274), F1 (T243M, rs28933389), F2 (G390V, rs28933390), S1 (FS117, rs398124632) in human genomic DNA.

More
gb HEMO GPIIIa (L33P) gb HEMO GPIIIa (L33P)

gb HEMO GPIIIa (L33P) gb HEMO GPIIIa (L33P)

The CE IVD real-time PCR kit is intended for detection of L33P mutation in GPIIIa (ITGB3) gene in human genomic DNA. Detection is based on real-time polymerase chain reaction (qPCR) using fluorescently labelled probes (allelic discrimination).

More
Recommended products
Recommended articles
About oligos

What is a Universal Base in oligo?

What is a Universal Base in oligo?

A universal base is a modified nucleobase that can pair (non-selectively) with more than one of the standard DNA bases (A, T, G, C), ideally without significantly destabilizing the duplex or interfering with polymerase activity. Inosine is the most common universal base, although other possibilities exist: Common Universal Bases in Oligonucleotide Synthesis Name Description Base-Pairing

More
About oligos

Backbone Modifications – Definition and Scope

Backbone Modifications – Definition and Scope

Backbone modifications alter the fundamental sugar–phosphate structure of an oligonucleotide. They are used to enhance stability, nuclease resistance, and binding affinity, making oligos suitable for demanding biological and therapeutic applications. Backbone modifications refer to chemical changes that affect the sugar–phosphate backbone of an oligonucleotide. These modifications alter the fundamental structure of the oligo rather than

More